Skip to main content
. 2022 Oct 12;13:1007790. doi: 10.3389/fphar.2022.1007790

TABLE 2.

Summary of the ΔG b° from the MD simulations and experimental IC50 of each inhibitor against each isozyme.

Inh/PKC ΔG°/(kcal/mol) IC50/μM Log(IC50/M) References
NVP/α −38.4 0.00095 −9.0223 Evenou et al. (2009)
PDS/β −41.2 0.002 −8.6990 Young et al. (2005)
RUB/β −38.8 0.0059 −8.2291 Tang et al. (2008)
ENZ/β −41.3 0.006 −8.2218 Graff et al. (2005)
PDS/α −38.1 0.007 −8.1549 Young et al. (2005)
DAT/αβ −25.2 0.3 −6.5229 Kim et al. (1998)
RUB/α −32.6 0.36 −6.4437 Tang et al. (2008)
Compound 3 −26.7 4.0 −5.3979 Kim et al. (1998)
Compound 3 −32.3
H4/αβ −22.8 10 −5.0000 Kinsella et al. (1992)
TT/αβ −16.7 10 −5.0000 Kim et al. (1998)
H7/αβ −19.9 40 −4.3979 Kinsella et al. (1992)

α and β: denotes that the experiments were 1:1 mixture; in those cases, the ΔG b° reported was taken as an average of the runs with the α and β isozymes.